Nearly a decade after becoming the first PCSK9 inhibitor to receive approval from the FDA, alirocumab (Praluent) has now received approval for pediatric patients with HeFH based on data from a phase 3 trial.
Viaskin milk patch shows promise in cow’s milk allergy, particularly in children aged 2-11 with 300 μg dose, though the other doses examined failed to prove significant benefit.
If you eat a diet that is very low in animal protein, very low in processed foods, very high in vegetables, fruits, whole grains and legumes with some nuts and seeds, you will live better and longer.